Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked up their private portfolios by 21.6% ($ weighted). There was an average mark-up of 17.8% (equal weighted).
  • Sentiment up:
  • Sentiment down:
  • In October, 31% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 52% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks.

Heat Map: August 31st, 2026 Reporting Period

21.6%

Appreciation/Depreciation of All Reported Holdings1

17.8%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Long Wall (ABL Space)
273.1%
CelLink
240.5%
Sila Nano
73.5%
Crusoe Energy
57.7%
Thriveworks
41.3%
Insitro
38.1%
Databricks
37.9%
Revolut
37.8%
goPuff
35.6%
Caidya (dMed)
33.4%
Anthropic
28.7%
SiFive
28.6%
Oura Health
25.2%
Dataminr
21.7%
Aledade
21.0%
Socure
20.3%
Resilience
19.9%
Skyhawk
18.8%
Tenstorrent
17.9%
Fanatics
15.7%
Honor Tech
15.5%
Starling Bank
15.4%
Rapyd
14.5%
Algolia
14.3%
Tory Burch
14.3%
Zipline
13.8%
Canva
13.3%
SambaNova
12.8%
Moloco
12.4%
Fabletics
12.0%
Element Bio
11.7%
Stripe
11.1%
Verily
10.0%
Bolt
9.8%
Farmers Business Network
8.3%
Nscale
8.1%
Rappi
8.0%
Quell
7.8%
Cardurion
7.4%
SiMa ai
7.3%
Insightec
7.2%
VAST Data
7.0%
Asimov
6.9%
Anduril
6.6%
Genesis Therapeutics
6.4%
Cleerly
5.7%
Allotera (Wugen)
5.5%
Discord
5.5%
Ant Group
5.3%
Runway AI
5.1%
OpenAI
4.5%
GupShup
4.4%
Mirador Therapeutics
4.4%
Bytedance
4.1%
World Labs
3.4%
Druva
2.3%
Xsight Labs
1.8%
JUUL
1.0%
LifeMine
0.7%
Bright Peak
0.6%
Diamond Foundry
0.4%
Sonoma Bio
0.4%
A24 Films
0.0%
Altos Labs
0.0%
Ankyra
0.0%
Arctic Wolf
0.0%
Blink Health
0.0%
DataRobot
0.0%
Deep Genomics
0.0%
Element Labs
0.0%
ElevateBio
0.0%
EndeavorBio
0.0%
FLEXE
0.0%
GOAT
0.0%
Goop
0.0%
Gusto
0.0%
HaulHub
0.0%
KoBold Metals
0.0%
Menlo Micro
0.0%
Nuro
0.0%
RefleXion Medical
0.0%
Savage X
0.0%
SecurityScorecard
0.0%
Superhuman (Grammarly)
0.0%
T-Knife
0.0%
City Therapeutics
-0.1%
Physical Intelligence
-0.1%
Retym
-0.1%
Triveni Bio
-0.1%
Waymo
-0.1%
Frore Systems
-0.2%
Epirus
-0.3%
Evozyne
-0.3%
Skyryse
-0.3%
Cellanome
-0.4%
MasterClass
-0.8%
Tipalti
-1.6%
Applied Intuition
-1.7%
PsiQuantum
-3.1%
Alif Semi
-3.3%
Galvanize
-4.1%
Lightmatter
-4.9%
Redwood Materials
-5.0%
Tarana
-6.0%
Medical Micro
-6.6%
Kardium
-11.4%
Bombas
-11.7%
Epic Games
-11.7%
Snyk
-12.6%
Treeline Bio
-14.6%
Unqork
-14.8%
Astranis
-18.8%
Asapp
-20.2%
Akeana
-22.8%
Castle Creek
-31.2%
PrognomIQ
-62.9%
Signifyd
-78.5%
VideoAmp
-80.0%
Empower Semi
-99.5%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked up their private portfolios by 21.6% ($ weighted). The appreciation of Anthropic was a main contributor to the mark up, as it’s widely held across funds. There was an average mark-up of 17.8% (equal weighted).

Long Wall (ABL Space) experienced the most significant mark-up, followed by CelLink, Sila Nano and Crusoe Energy. CleanTech, AI & Machine Learning and FinTech saw the largest mark-ups across sectors.

Empower Semi experienced the most significant mark-down followed by VideoAmp, Signifyd and PrognomIQ. Among sectors, CloudTech & DevOps, Semiconductors and EdTech saw the most significant mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesRobustness Score3ZX Index Values4 vs. Fund Marks
Applied Intuition2+90.20%
Zipline2+89.70%
Diamond Foundry1+61.70%
Anduril7+60.20%
Lightmatter5+25.00%
Bytedance3+23.00%
Discord2+22.90%
Dataminr2+16.60%
OpenAI6+13.20%
Anthropic7+12.80%
Tenstorrent7+8.70%
Epic Games1+3.50%
Gusto2+2.80%
Stripe7+2.60%
Reflection AI3+0.20%
Databricks3+0.00%
Redwood Materials1-0.50%
Revolut2-5.40%
Canva2-7.20%
Bolt1-13.10%
Waymo2-18.90%
VAST Data3-19.50%
KoBold Metals1-20.10%
Crusoe Energy4-27.00%
PsiQuantum2-34.00%
Arctic Wolf1-34.30%
Snyk1-38.40%
SambaNova1-43.30%
Fanatics1-50.00%

3 ZXData Robustness Score is an internally developed metric to assign confidence levels to the underlying data used in constructing ZXData output metrics. The ZXData Robustness Score is calculated on a scale of 1 to 10 for each company, based on the number of executed trades, number of buy and sell orders submitted to ZX and skewness of the order book.
4 ZX Index Value is an internally developed metric that reflects secondary values for private companies using an algorithmic approach based on the values sourced from ZX and ZXData partners. The algorithm used to calculate ZX Index Values incorporates both executed transaction values and bid and ask pricing.

In October, 31% of companies with ZX Index Values showed a difference of 10% or less compared to Fund Marks, and 52% of companies with ZX Index Values showed a difference of 20% or less compared to Fund Marks. Among the companies, Applied Intuition, Zipline and Diamond Foundry had the highest positive variance in reported marks versus ZX Index Values. Fanatics, SambaNova and Snyk had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev5$ Weighted AvgMaxMin
PrognomIQ1.24$0.07$0.32$0.04
Unqork.46$4.25$5.78$1.70
Honor Tech.44$0.71$0.95$0.30
Resilience.38$5.51$22.39$4.43
Superhuman (Grammarly).33$16.06$25.60$13.10

5 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period PrognomIQ ($0.04 - $0.32) saw the highest share price variance across funds followed by Unqork ($1.70 - $5.78) and Honor Tech ($0.30 - $0.95).

Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal6 (# = consecutive prior qtrs marked down or flat)
Resilience
17
CelLink
11
Dataminr, Sila Nano
6
Long Wall (ABL Space)
5
Negative Trend Reversal7 (# = consecutive prior qtrs marked up or flat)
PsiQuantum
5
Galvanize
4
Lightmatter
4
PrognomIQ
3

6 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
7 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Resilience saw its first positive reversal in seventeen quarters while CelLink saw its first positive reversal in eleven quarters. PsiQuantum saw its first negative reversal in five quarters while Galvanize and Lightmatter saw their first negative reversals in four quarters.

Disclaimer

This report is based on data reported by 300+ funds and $120+ billion of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report October not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right